William W. Ericson, Director, 10% Owner at Adamas Pharmaceuticals Inc (ADMS), bought 168,752 shares at $15.65 ($2.6M) on 2016-09-12, disclosed to the SEC on 2016-09-14.
Open-market purchase of $2.6M ADMS by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.65 | 22,342 | $350K | 13.3% |
| 2 | $15.65 | 22,342 | $350K | 13.3% |
| 3 | $15.56 | 62,034 | $965K | 36.7% |
| 4 | $15.56 | 62,034 | $965K | 36.7% |
| Total | $15.58 avg | 168,752 | $2.6M | 100% |
| Filing → |
| ADMS | BUY | 2016-09-16 | $2.1M | — | Filing → |
| ADMS | BUY | 2016-09-09 | $1.9M | — | Filing → |
| ADMS | BUY | 2016-09-07 | $1.4M | — | Filing → |